Living with advanced head and neck cancer is incredibly difficult, especially for older patients. Many patients over age 70 may not be strong enough to handle high doses of standard chemotherapy. This creates a difficult choice for doctors and families trying to find the best way to treat the cancer while keeping the patient comfortable.
A new trial is looking at a different approach. Researchers are testing a lower dose of a drug called cisplatin, given weekly, alongside radiation. This plan is specifically designed for patients who are not fit for the standard high-dose treatments. The goal is to see if this combination improves overall survival compared to using radiation alone.
Because this is a trial protocol, the study is still ongoing. No results are available yet, and the safety of this specific dosing schedule has not been measured. This study will involve 250 patients across 59 different locations to see if this modified treatment is a viable option for those who cannot tolerate standard care.
